Jin Long Chen
Director/Board Member bei TENAYA THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Jin Long Chen was the founder of NGM Biopharmaceuticals, Inc. (founded in 2007) and TCG Labs-Soleil (founded in 2023), where he holds the titles of Director & Chief Scientific Officer and Managing Partner & CEO, respectively.
He is currently working as an Independent Director at Tenaya Therapeutics, Inc. since 2016.
In the past, he worked as Vice President-Research at Amgen, Inc. from 2004 to 2008 and as Vice President-Biology at Tularik, Inc. Dr. Chen holds a doctorate degree from the University of California, Berkeley, a graduate degree from National Taiwan University, and an undergraduate degree from Fu Jen Catholic University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.03.2023 | 1 133 893 ( 1,36% ) | 2 Mio $ | 31.03.2024 | |
| 31.03.2024 | 25 000 ( 0,03% ) | 130 750 $ | 31.03.2024 |
Aktive Positionen von Jin Long Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Director/Board Member | 01.10.2016 |
Ehemalige bekannte Positionen von Jin Long Chen
| Unternehmen | Position | Ende |
|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Founder | 04.04.2023 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 01.01.2008 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Jin Long Chen
| University of California, Berkeley | Doctorate Degree |
| National Taiwan University | Graduate Degree |
| Fu Jen Catholic University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
